B-type natriuretic peptide is an independent predictor for cardiovascular death in patients with no clinical signs of ventricular dysfunction after acute myocardial infarction

Yanzhou Zhang, Lexin Wang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

B-type natriuretic peptide (BNP) is released from cardiac ventricles in response to increased wall tension in patients with heart failure. It has been used as a biochemical marker for the diagnosis of congestive heart failure. BNP is also increased in patients with acute myocardial infarction, and is associated with an increased risk of cardiovascular mortality in those with impaired left ventricular function after myocardial infarction. We hypothesized that an increase in BNP soon after acute myocardial infarction is an independent predictor for long-term prognosis in patients with no clinical signs of left ventricular function.
Original languageEnglish
Pages (from-to)1076-1078
Number of pages3
JournalMedical Hypotheses
Volume67
Issue number5
DOIs
Publication statusPublished - 2006

Fingerprint

Ventricular Dysfunction
Brain Natriuretic Peptide
Myocardial Infarction
Left Ventricular Function
Heart Failure
Heart Ventricles
Biomarkers
Mortality

Cite this

@article{be4a0a69695940ecb6b9715d33c01583,
title = "B-type natriuretic peptide is an independent predictor for cardiovascular death in patients with no clinical signs of ventricular dysfunction after acute myocardial infarction",
abstract = "B-type natriuretic peptide (BNP) is released from cardiac ventricles in response to increased wall tension in patients with heart failure. It has been used as a biochemical marker for the diagnosis of congestive heart failure. BNP is also increased in patients with acute myocardial infarction, and is associated with an increased risk of cardiovascular mortality in those with impaired left ventricular function after myocardial infarction. We hypothesized that an increase in BNP soon after acute myocardial infarction is an independent predictor for long-term prognosis in patients with no clinical signs of left ventricular function.",
author = "Yanzhou Zhang and Lexin Wang",
note = "Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Medical Hypotheses. ISSNs: 0306-9877;",
year = "2006",
doi = "10.1016/j.mehy.2006.02.052",
language = "English",
volume = "67",
pages = "1076--1078",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "5",

}

TY - JOUR

T1 - B-type natriuretic peptide is an independent predictor for cardiovascular death in patients with no clinical signs of ventricular dysfunction after acute myocardial infarction

AU - Zhang, Yanzhou

AU - Wang, Lexin

N1 - Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Medical Hypotheses. ISSNs: 0306-9877;

PY - 2006

Y1 - 2006

N2 - B-type natriuretic peptide (BNP) is released from cardiac ventricles in response to increased wall tension in patients with heart failure. It has been used as a biochemical marker for the diagnosis of congestive heart failure. BNP is also increased in patients with acute myocardial infarction, and is associated with an increased risk of cardiovascular mortality in those with impaired left ventricular function after myocardial infarction. We hypothesized that an increase in BNP soon after acute myocardial infarction is an independent predictor for long-term prognosis in patients with no clinical signs of left ventricular function.

AB - B-type natriuretic peptide (BNP) is released from cardiac ventricles in response to increased wall tension in patients with heart failure. It has been used as a biochemical marker for the diagnosis of congestive heart failure. BNP is also increased in patients with acute myocardial infarction, and is associated with an increased risk of cardiovascular mortality in those with impaired left ventricular function after myocardial infarction. We hypothesized that an increase in BNP soon after acute myocardial infarction is an independent predictor for long-term prognosis in patients with no clinical signs of left ventricular function.

U2 - 10.1016/j.mehy.2006.02.052

DO - 10.1016/j.mehy.2006.02.052

M3 - Article

VL - 67

SP - 1076

EP - 1078

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 5

ER -